{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:07:59Z","timestamp":1791025679548,"version":"4.1.0"},"reference-count":26,"publisher":"American Society for Microbiology","issue":"19","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Marburg virus (MARV) has been associated with sporadic episodes of hemorrhagic fever, including a recent highly publicized outbreak in Angola that produced severe disease and significant mortality in infected patients. MARV is also considered to have potential as a biological weapon. Recently, we reported the development of a promising attenuated, replication-competent vaccine against MARV based on recombinant vesicular stomatitis virus (VSV) expressing the glycoprotein of the Musoke strain of MARV (VSV\u0394G\/MARVGP-Musoke). We used this vaccine to demonstrate complete protection of cynomolgus monkeys against a homologous MARV challenge. While these results are highly encouraging, an effective vaccine would need to confer protection against all relevant strains of MARV. Here, we evaluated the protective efficacy of the VSV\u0394G\/MARVGP-Musoke vaccine against two heterologous MARV strains, the seemingly more pathogenic Angola strain and the more distantly related Ravn strain. In this study, seven cynomolgus monkeys were vaccinated with the VSV\u0394G\/MARVGP-Musoke vector. Three of these animals were challenged with the Angola strain, three with the Ravn strain, and a single animal with the Musoke strain of MARV. Two animals served as controls and were each injected with a nonspecific VSV vector; these controls were challenged with the Angola and Ravn strains, respectively. Both controls succumbed to challenge by day 8. However, none of the specifically vaccinated animals showed any evidence of illness either from the vaccination or from the MARV challenges and all of these animals survived. These data suggest that the VSV\u0394G\/MARVGP-Musoke vaccine should be sufficient to protect against all known MARV strains.<\/jats:p>","DOI":"10.1128\/jvi.00959-06","type":"journal-article","created":{"date-parts":[[2006,9,14]],"date-time":"2006-09-14T03:35:27Z","timestamp":1158204927000},"page":"9659-9666","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":119,"title":["Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine"],"prefix":"10.1128","volume":"80","author":[{"given":"Kathleen M.","family":"Daddario-DiCaprio","sequence":"first","affiliation":[{"name":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"},{"name":"Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"},{"name":"Uniformed Services University of the Health Sciences, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Stro\u0308her","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[{"name":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Grolla","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Fritz","sequence":"additional","affiliation":[{"name":"Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Feldmann","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Microbiology"},{"name":"Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.18.2391"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890060205"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300994"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(03)00122-1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68546-2"},{"key":"e_1_3_2_7_2","first-page":"645","year":"2004","unstructured":"Feldmann, H., T. W. Geisbert, P. B. Jahrling, H. D. Klenk, S. V. Netesov, C. J. Peters, A. Sanchez, R. Swanepoel, and V. E. Volchkov. 2004. Filoviridae, p. 645-653. In C. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: eighth report of the International Committee on Taxonomy of Viruses. Elsevier, London, United Kingdom.","journal-title":"Virus taxonomy: eighth report of the International Committee on Taxonomy of Viruses"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5458-5465.2004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020183"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9367"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Hevey M. D. Negley A. Staley and A. Schmaljohn. 2001. Determination of vaccine components required for protecting cynomolgus macaques against genotypically divergent isolates of Marburg virus abstr. W36-4. Abstr. 20th Annu. Meet. Am. Soc. Virol. Madison Wis.","DOI":"10.1016\/S0264-410X(01)00353-X"},{"key":"e_1_3_2_12_2","unstructured":"International AIDS Vaccine Initiative. 2005. Annual AIDS vaccine meeting highlights recent data from clinical trials and lessons on recruitment and retention of volunteers. International AIDS Vaccine Initiative New York N.Y. [Online.] http:\/\/www.iavireport.org\/Issues\/Issue9-4\/promise.asp\n."},{"key":"e_1_3_2_13_2","unstructured":"International Society for Infectious Diseases. 2005. Marburg hemorrhagic fever\u2014Angola archive no. 20051108.3269. International Society for Infectious Diseases Brookline Mass. [Online.] http:\/\/www.promedmail.org\n."},{"key":"e_1_3_2_14_2","first-page":"101","volume":"11","year":"1996","unstructured":"Johnson, E. D., B. K. Johnson, D. Silverstein, P. Tukei, T. W. Geisbert, A. N. Sanchez, and P. B. Jahrling. 1996. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. Suppl.11:101-114.","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1258"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-996-0005-9"},{"key":"e_1_3_2_17_2","first-page":"1","year":"1971","unstructured":"Martini, G. 1971. Marburg virus disease: clinical syndrome, p. 1-9. In G. A. Martini and R. Siegert (ed.), Marburg virus disease. Springer-Verlag, New York, N.Y.","journal-title":"Marburg virus disease"},{"key":"e_1_3_2_18_2","unstructured":"National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington D.C."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.21.13231-13238.2005"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00482-2"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.8.3602"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8902"},{"key":"e_1_3_2_23_2","first-page":"816","year":"1982","unstructured":"Smith, D. H., B. K. Johnson, M. Isaacson, R. Swanapoel, K. M. Johnson, M. Killey, A. Bagshawe, T. Siongok, and W. K. Keruga. 1982. Marburg-virus disease in Kenya. Lanceti:816-820.","journal-title":"Lancet"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01876"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/35046108"},{"key":"e_1_3_2_26_2","first-page":"1121","year":"1996","unstructured":"Wagner, R. R., and J. K. Rose. 1996. Rhabdoviridae: the viruses and their replication, p. 1121-1135. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, Pa.","journal-title":"Fields virology"},{"key":"e_1_3_2_27_2","first-page":"158","volume":"80","year":"2005","unstructured":"World Health Organization. 2005. Marburg haemorrhagic fever, Angola. Wkly. Epidemiol. Rec.80:158-159.","journal-title":"Wkly. Epidemiol. Rec."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00959-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00959-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:30:25Z","timestamp":1646476225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00959-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":26,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1128\/JVI.00959-06"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00959-06","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"2006-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-07-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-10-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}